United States · Bill · HR
H.R. 5309 (102nd)
To provide an antitrust exemption for medical self-regulatory entities when engaged in standard setting and enforcement activities designed to promote the quality of care and for other purposes.
Introduced
3 June 1992
Last action
—
Status
Referred to the Subcommittee on Economic and Commercial Law.
Sponsors
—
Subjects
Discovery layer
Source updated
2 June 2021
Summary
Bars the recovery of damages, interest, costs, or attorney fees under the Clayton Act or similar State laws from any medical self-regulatory entity as a result of standard setting or enforcement activities designed to promote the quality of health care.
This text is taken from the official record. PoliticalRepo does not editorialize.
Timeline
No timeline events have been ingested for this record yet.
Votes
No vote records are attached yet.
Versions
No version snapshots stored. Document URLs remain at the source.
Documents
2 official files
Introduced in House (text)
Introduced in House (text)
Introduced in House · EN
Introduced in House
summary · EN · 3 June 1992
Sponsors
No sponsors or actors listed by the source.
Related records
No cross-record relationships stored yet.
Sources
PoliticalRepo is an index and interpretation layer, not the authoritative legal source.
- Official source: https://www.congress.gov/bill/102nd-congress/house-bill/5309
- Open data entity: https://api.congress.gov/v3/bill/102/hr/5309